Jamieson NV - Search Results

1

Alemtuzumab (CAMPATH 1H) induction therapy in cadaveric kidney transplantation--efficacy and safety at five years.

Watson CJ, Bradley JA, Friend PJ, Firth J, Taylor CJ, Bradley JR, Smith KG, Thiru S, Jamieson NV, Hale G, Waldmann H, Calne R. Watson CJ, et al. Among authors: jamieson nv. Am J Transplant. 2005 Jun;5(6):1347-53. doi: 10.1111/j.1600-6143.2005.00822.x. Am J Transplant. 2005. PMID: 15888040 Free article.

2

Cadaveric renal transplantation in elderly recipients: is it worthwhile?

Morris GE, Jamieson NV, Small J, Evans DB, Calne R. Morris GE, et al. Among authors: jamieson nv. Nephrol Dial Transplant. 1991;6(11):887-92. doi: 10.1093/ndt/6.11.887. Nephrol Dial Transplant. 1991. PMID: 1775255

3

CsA levels in the early posttransplant period--predictive of chronic rejection in liver transplantation?

Soin AS, Rasmussen A, Jamieson NV, Watson CJ, Friend PJ, Wight DG, Calne RY. Soin AS, et al. Among authors: jamieson nv. Transplantation. 1995 Apr 27;59(8):1119-23. Transplantation. 1995. PMID: 7732557

4

Sirolimus: a potent new immunosuppressant for liver transplantation.

Watson CJ, Friend PJ, Jamieson NV, Frick TW, Alexander G, Gimson AE, Calne R. Watson CJ, et al. Among authors: jamieson nv. Transplantation. 1999 Feb 27;67(4):505-9. doi: 10.1097/00007890-199902270-00002. Transplantation. 1999. PMID: 10071017

5

Campath IH allows low-dose cyclosporine monotherapy in 31 cadaveric renal allograft recipients.

Calne R, Moffatt SD, Friend PJ, Jamieson NV, Bradley JA, Hale G, Firth J, Bradley J, Smith KG, Waldmann H. Calne R, et al. Among authors: jamieson nv. Transplantation. 1999 Nov 27;68(10):1613-6. doi: 10.1097/00007890-199911270-00032. Transplantation. 1999. PMID: 10589966 Clinical Trial.

6

Prope tolerance with induction using Campath 1H and low-dose cyclosporin monotherapy in 31 cadaveric renal allograft recipients.

Calne R, Moffatt SD, Friend PJ, Jamieson NV, Bradley JA, Hale G, Firth J, Bradley J, Smith KG, Waldmann H. Calne R, et al. Among authors: jamieson nv. Nihon Geka Gakkai Zasshi. 2000 Mar;101(3):301-6. Nihon Geka Gakkai Zasshi. 2000. PMID: 10773997 Clinical Trial.

7

Outcome of transplantation using kidneys from controlled (Maastricht category 3) non-heart-beating donors.

Sudhindran S, Pettigrew GJ, Drain A, Shrotri M, Watson CJ, Jamieson NV, Bradley JA. Sudhindran S, et al. Among authors: jamieson nv. Clin Transplant. 2003 Apr;17(2):93-100. doi: 10.1034/j.1399-0012.2003.00014.x. Clin Transplant. 2003. PMID: 12709073

8

Treatment of graft-versus-host disease after liver transplantation with basiliximab followed by bowel resection.

Sudhindran S, Taylor A, Delriviere L, Collins VP, Liu L, Taylor CJ, Alexander GJ, Gimson AE, Jamieson NV, Watson CJ, Gibbs P. Sudhindran S, et al. Among authors: jamieson nv. Am J Transplant. 2003 Aug;3(8):1024-9. doi: 10.1034/j.1600-6143.2003.00108.x. Am J Transplant. 2003. PMID: 12859540 Free article.

9

Monitoring systemic donor lymphocyte macrochimerism to aid the diagnosis of graft-versus-host disease after liver transplantation.

Taylor AL, Gibbs P, Sudhindran S, Key T, Goodman RS, Morgan CH, Watson CJ, Delriviere L, Alexander GJ, Jamieson NV, Bradley JA, Taylor CJ. Taylor AL, et al. Among authors: jamieson nv. Transplantation. 2004 Feb 15;77(3):441-6. doi: 10.1097/01.TP.0000103721.29729.FE. Transplantation. 2004. PMID: 14966423

10

Quality of life up to 30 years following liver transplantation.

Desai R, Jamieson NV, Gimson AE, Watson CJ, Gibbs P, Bradley JA, Praseedom RK. Desai R, et al. Among authors: jamieson nv. Liver Transpl. 2008 Oct;14(10):1473-9. doi: 10.1002/lt.21561. Liver Transpl. 2008. PMID: 18825684 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

209 results

Search Page